Literature DB >> 22429150

Inflammation and Toll-like receptor ligation differentially affect the osteogenic potential of human mesenchymal stromal cells depending on their tissue origin.

Gordana Raicevic1, Mehdi Najar, Karlien Pieters, Cecile De Bruyn, Nathalie Meuleman, Dominique Bron, Michel Toungouz, Laurence Lagneaux.   

Abstract

Mesenchymal stromal cells (MSCs) can be isolated not only from bone marrow (BM) but also from other tissues, including adipose tissue (AT) and umbilical cord Wharton's Jelly (WJ). Thanks to their ability to differentiate into various cell types, MSC are considered attractive candidates for cell-based regenerative therapy. In degenerative clinical settings, inflammation or infection is often involved. In the present work, we hypothesized that an inflammatory environment and/or Toll-like receptor (TLR) ligation could affect the MSC differentiation potential. MSC were isolated from BM, AT, and WJ. Inflammation was mimicked by a cytokine cocktail, and TLR activation was induced through TLR3 and TLR4 ligation. Osteogenesis was chosen as a model for differentiation. Osteogenic parameters were evaluated by measuring Ca2+ deposits and alkaline phosphatase (ALP) activity at day 7, 14, and 21 of the culture in an osteogenic medium. Our results show that WJ-MSC exhibit a much lower osteogenic potential than the other two MSC types. However, inflammation was able to strongly increase the osteogenic differentiation of WJ-MSC as calcification, and ALP activity appeared as early as day 7. However, this latter enzymatic activity remained much lower than that disclosed by BM-MSC. TLR3 or TLR4 triggering increased the osteogenesis in AT- and, to lesser extent, in BM-MSC. In conclusion, WJ-MSC constitutively disclose a lower osteogenic potential as compared with BM and AT-MSC, which is not affected by TLR triggering but is strongly increased by inflammation, then reaching the level of BM-MSC. These observations suggest that WJ-MSC could constitute an alternative of BM-MSC for bone regenerative applications, as WJ is an easy access source of large amounts of MSC that can effectively differentiate into osteoblasts in an inflammatory setting.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22429150     DOI: 10.1089/ten.TEA.2011.0434

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  24 in total

Review 1.  TLR4 signalling in osteoarthritis--finding targets for candidate DMOADs.

Authors:  Rodolfo Gómez; Amanda Villalvilla; Raquel Largo; Oreste Gualillo; Gabriel Herrero-Beaumont
Journal:  Nat Rev Rheumatol       Date:  2014-12-16       Impact factor: 20.543

2.  Human Fetal Cartilage-Derived Progenitor Cells Exhibit Anti-Inflammatory Effect on IL-1β-Mediated Osteoarthritis Phenotypes In Vitro.

Authors:  Jiyoung Kim; An Nguyen-Thuy Tran; Ji Young Lee; Sang-Hyug Park; So Ra Park; Byoung-Hyun Min; Byung Hyune Choi
Journal:  Tissue Eng Regen Med       Date:  2022-08-06       Impact factor: 4.451

3.  Gastrointestinal microbes interact with canine adipose-derived mesenchymal stem cells in vitro and enhance immunomodulatory functions.

Authors:  Amir Kol; Soraya Foutouhi; Naomi J Walker; Nguyet T Kong; Bart C Weimer; Dori L Borjesson
Journal:  Stem Cells Dev       Date:  2014-06-26       Impact factor: 3.272

Review 4.  Current View on Osteogenic Differentiation Potential of Mesenchymal Stromal Cells Derived from Placental Tissues.

Authors:  Gabriela Kmiecik; Valentina Spoldi; Antonietta Silini; Ornella Parolini
Journal:  Stem Cell Rev Rep       Date:  2015-08       Impact factor: 5.739

5.  Effects of toll-like receptors 3 and 4 in the osteogenesis of stem cells.

Authors:  Chen Qi; Xu Xiaofeng; Wang Xiaoguang
Journal:  Stem Cells Int       Date:  2014-12-25       Impact factor: 5.443

6.  Activation of TLR3 induces osteogenic responses in human aortic valve interstitial cells through the NF-κB and ERK1/2 pathways.

Authors:  Qiong Zhan; Rui Song; Qingchun Zeng; Qingzhou Yao; Lihua Ao; Dingli Xu; David A Fullerton; Xianzhong Meng
Journal:  Int J Biol Sci       Date:  2015-03-20       Impact factor: 6.580

7.  Evidences of early senescence in multiple myeloma bone marrow mesenchymal stromal cells.

Authors:  Thibaud André; Nathalie Meuleman; Basile Stamatopoulos; Cécile De Bruyn; Karlien Pieters; Dominique Bron; Laurence Lagneaux
Journal:  PLoS One       Date:  2013-03-21       Impact factor: 3.240

8.  Lipopolysaccharide differentially affects the osteogenic differentiation of periodontal ligament stem cells and bone marrow mesenchymal stem cells through Toll-like receptor 4 mediated nuclear factor κB pathway.

Authors:  Chenghua Li; Bei Li; Zhiwei Dong; Li Gao; Xiaoning He; Li Liao; Chenghu Hu; Qintao Wang; Yan Jin
Journal:  Stem Cell Res Ther       Date:  2014-05-27       Impact factor: 6.832

9.  Toll like receptor 3 & 4 responses of human turbinate derived mesenchymal stem cells: stimulation by double stranded RNA and lipopolysaccharide.

Authors:  Se Hwan Hwang; Hye Kyung Cho; Sang Hi Park; WeonSun Lee; Hee Jin Lee; Dong Chang Lee; Jeong Hoon Oh; Sun Hwa Park; Tai-Gyu Kim; Hyun-Jung Sohn; Jun Myung Kang; Sung Won Kim
Journal:  PLoS One       Date:  2014-07-08       Impact factor: 3.240

10.  TLR4 Activation Promotes Bone Marrow MSC Proliferation and Osteogenic Differentiation via Wnt3a and Wnt5a Signaling.

Authors:  Xiaoqing He; Hai Wang; Tao Jin; Yongqing Xu; Liangbin Mei; Jun Yang
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.